Below is Validea's guru fundamental report for BIONTECH SE - ADR (BNTX). Of the 22 guru strategies we follow, BNTX rates highest using our Value Investor model based on the published strategy of ...

PFE stock is likely to be a great pick for value investors, considering its cheap valuation, as well as for income investors ...

Morgan Stanley raised the firm’s price target on BioNTech (BNTX) to $140 from $139 and keeps an Overweight rating on the shares. The firm ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $139.00.

Vetter, Chairman of the Supervisory Board of ITM. " The expansion of our Supervisory Board and its insights ensures that ITM ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Health Secretary Robert F. Kennedy Jr., who has often linked vaccines to the neurodevelopmental disorder autism, said ...

At close: April 9 at 4:00:04 PM EDT ...

At close: April 8 at 4:00:01 p.m. EDT ...

Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why ...

Novavax (NASDAQ: NASDAQ:NVAX) stock plummeted 24% after comments from Health and Human Services Secretary Robert F. Kennedy Jr. suggested a shift in government priorities away from the company’s ...